RxDoctor Payments Data

Don Park, MD

Orthopaedic Surgery of the Spine · Orange, CANPI 1578750774

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $580,545 of the $849,366 with a category attached, or 68.4%. 29 manufacturers reported payments, led by Alphatec Spine, Inc at 51.2% of the total. 2025 is the largest year on record at $334,802, 7.2 times the $46,408 reported in 2019. Among orthopaedic surgery of the spine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$849,366in general payments, 2019–2025

Across 409 payments — averaging $2076.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$435K
  • Orthofix Medical, Inc.$152K
  • Amplify Surgical, Inc.$86K
  • Globus Medical$62K
  • Seaspine Orthopedics Corporation$55K
  • Stryker$42K
  • plus $17K from 23 others
$7,500in research payments, 2019–2025

Across 1 payment — averaging $7500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GS Solutions, Inc.$8K
$19,602in ownership & investment interests, 2019–2025

Across 1 payment — averaging $19,602 each. An ownership or investment interest held by the physician or an immediate family member.

  • Amplify Surgical, Inc.$20K

What the payments were for

  • Royalty or licence$580,54568%
  • Consulting fees$176,10121%
  • Speaking & faculty fees$17,2752%
  • Travel & lodging$55,0526%
  • Food & beverage$20,2852%
  • Entertainment$1070%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$849,366 in reported general payments places this provider in the 90th percentile of 288 orthopaedic surgery of the spine providers in California.

See all orthopaedic surgery of the spine providers in California

Medicare billing

Part B allowed, 2024
$149,968
Medicare patients
235
Services billed
531

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib103$4,499
Gabapentin33$428
Oxycodone Hcl59$361
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$331
Tizanidine Hcl53$309
Methylprednisolone37$243

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Orange

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →